B+
Bull case
25%
Probability
Target price
$11.50
Analysis reference price unavailable
Analysis 2026-10-10 · RankAlpha Sentiment Codex
OPRX
OptimizeRxBNasdaq / Health Care Equipment & Services
Last Price
Quote time unavailable
Current thesis
If second-half revenue reaches guidance and OpenPath creates measurable advertiser demand, platform distribution could support improved growth. Management reported Q2 revenue and adjusted EBITDA above consensus, without quantifying the beat in its release.
Posture
Constructive
Lead driver
Value
What changed
Value remains the lead driver in the composite, 7D delta -0.7.
What can break
A planned CFO transition effective January 1, 2027 adds an execution item to monitor, although the company describes it as planned succession [#SEC-8K-2026-08-12].
Momentum
90
Value
66
Sentiment
44
Setup hits (3d)
0 · Net Neutral
AI TargetsBase $8.80 · Bull $11.50 · Bear $5.50Analysis 2026-10-10; returns require an exact persisted reference.
Data freshness
Prices
Unavailable: Price unavailable
Fundamentals
As of 2026-10-23 • Vendor: Data Vendor v1
Scores
As of 2026-10-23 • Model: HYBRID_IC_RP
AI Memo
As of 2026-10-10 • Model: RankAlpha Sentiment Codex
Investment thesisAs of 2026-10-23
Investment thesis
As of 2026-10-23
Grade is the composite factor band; factor scores use a 0–100 scale. Confidence describes evidence quality, not a probability of return. Score date: 2026-10-23. Definitions
Supporting evidence
What
Grade B · Constructive
Confidence Medium · Net Neutral
Target $12.60
Why
Momentum90 · Δ7d +2.8
Value66 · Δ7d -0.7
Sentiment44 · Δ7d -9.7
So what
Strength-led posture (Net Neutral). Favor watchlist adds and disciplined entries.
Confirming evidence
- • Value remains the lead driver in the composite, 7D delta -0.7.
Contradictions & invalidation
- • A planned CFO transition effective January 1, 2027 adds an execution item to monitor, although the company describes it as planned succession [#SEC-8K-2026-08-12].
- • Meeting 2026 revenue guidance requires approximately $54.65 million–$59.65 million of second-half revenue after $40.35 million in the first half. Company Q2 results.
- • The required second-half revenue step-up is substantial against a 30% Q2 year-over-year decline and 90% net revenue retention.
Catalyst clock
2026-12-31
OpenPath inventory availability
Lead driver: Value · See fundamentals
Momentum
90
8% active weight
Current posture
7d trendSoftening
Δ7d
+2.8
Δ21d
+8.2
Value
66
47% active weight
Current posture
7d trendFlat
Δ7d
-0.7
Δ21d
-0.7
Sentiment
44
45% active weight
Current posture
7d trendSoftening
Δ7d
-9.7
Δ21d
-23.0
Why this grade
Composite grade B. Momentum 89.6 / Value 66.3 / Sentiment 44.5
Scenario snapshot
Scenario probability is memo-authored likelihood, not forecast certainty. Targets belong to the analysis dated 2026-10-10. Scenario method
Most likely
B
Base case
50%
Probability
Target price
$8.80
Analysis reference price unavailable
Analysis 2026-10-10 · RankAlpha Sentiment Codex
B-
Bear case
25%
Probability
Target price
$5.50
Analysis reference price unavailable
Analysis 2026-10-10 · RankAlpha Sentiment Codex
Fundamentals (TTM)As of 2026-10-23
Fundamentals (TTM)
As of 2026-10-23
Market Cap
$172.35M
Beta
1.18
Shares Out
18.84M
P/E (TTM)
9274.6
P/S (TTM)
2.24
P/FCF (TTM)
21.22
Rev YoY
-29.8%
EPS YoY
-146.4%
Gross Margin
+68.9%
Op Margin
+11.4%
Net Debt
$2.74M
Current Ratio
5.58
As of 2026-10-23 • Updated nightlySource: Internal modelMethods & Data